Try a new search

Format these results:

Searched for:

person:grifoj01

Total Results:

476


WHAT'S THE SCORE?: A QUANTITATIVE MEANS TO ASSESS EMBRYO QUALITY (EQ) [Meeting Abstract]

Knopman, J. M.; Krey, L. C.; McCaffrey, C.; Noyes, N.; Hodes-Wertz, B.; Grifo, J. A.
ISI:000281441000085
ISSN: 0015-0282
CID: 113762

GENERATION AND CHARACTERIZATION OF DISEASE-SPECIFIC HUMAN EMBRYONIC STEM CELLS FROM GENETICALLY ABNORMAL EMBRYOS [Meeting Abstract]

Hansis, C.; Rice, C. E.; Lehmann, R.; Grifo, J. A.
ISI:000281441000101
ISSN: 0015-0282
CID: 113763

ARE WE UNDERESTIMATING THE PREVALENCE OF ANEUPLOIDY- RELATED MISCARRIAGES? A DESCRIPTION OF CYTOGENETIC RESULTS FROM PRODUCTS OF CONCEPTION (POC) AFTER DILATION AND CURETTAGE (D&C) [Meeting Abstract]

Werner, M. D.; Reh, A.; Perle, M. A.; Grifo, J.
ISI:000281441000143
ISSN: 0015-0282
CID: 113764

VALIDATION AND FIRST CLINICAL APPLICATION OF KARYOMAPPING FOR PREIMPLANTATION DIAGNOSIS (PGD) OF GAUCHER DISEASE COMBINED WITH 24 CHROMOSOME SCREENING [Meeting Abstract]

Handyside, A. H.; Grifo, J.; Prates, R.; Tormasi, S.; Fischer, J.; Munne, S.
ISI:000281441000272
ISSN: 0015-0282
CID: 113767

OOCYTE CRYOPRESERVATION: AN ALTERNATIVE MODEL FOR GAMETE DONATION [Meeting Abstract]

Knopman, J. M.; Noyes, N.; LaBella, P.; Licciardi, F.; Grifo, J. A.
ISI:000281441000396
ISSN: 0015-0282
CID: 113768

DOES NEWLY AVAILABLE 24-CHROMOSOME (24C) PREIMPLANTATION GENETIC SCREENING (PGS) IMPROVE IVF OUTCOMES IN PATIENTS AT RISK FOR ANEUPLOIDY? FIRST YEAR'S EXPERIENCE AT A LARGE, UNIVERSITY-BASED CENTER [Meeting Abstract]

Devine, K.; Knopman, J.; Adler, A.; Berkeley, A.; Grifo, J.
ISI:000281441000418
ISSN: 0015-0282
CID: 113769

WHAT IS A NORMAL THYROID STIMULATING HORMONE (TSH) LEVEL? EFFECTS OF STRICTER TSH THRESHOLDS ON PREGNANCY OUTCOMES AFTER IVF [Meeting Abstract]

Reh, A.; Danoff, A.; Grifo, J.
ISI:000281441000641
ISSN: 0015-0282
CID: 113772

EFFECT OF AUTOIMMUNE THYROID DISEASE (AITD) IN OLDER, EUTHYROID INFERTILE WOMEN UNDERGOING IN VITRO FERTILIZATION (IVF) [Meeting Abstract]

Reh, A.; Im, S.; Amarosa, A.; Rolnitzky, L.; Grifo, J.; Danoff, A.
ISI:000281441000647
ISSN: 0015-0282
CID: 113773

ESTRADIOL (E2), PROGESTERONE (P), AND HUMAN CHORIONIC GONADOTROPIN (hCG) AS PREDICTORS OF PREGNANCY OUTCOME IN IN-VITRO FERTILIZATION (IVF) [Meeting Abstract]

Weinerman, R. S.; Mullin, C.; Grifo, J. A.
ISI:000281441000887
ISSN: 0015-0282
CID: 113774

Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors

Noyes, Nicole; Labella, Patty Ann; Grifo, James; Knopman, Jaime M
PURPOSE: To compare oocyte cryopreservation cycles performed in cancer patients to those of infertile women. METHODS: Cancer patients referred for fertility preservation underwent counseling in compliance with the ASRM; those electing oocyte cryopreservation were included. Ovarian stimulation was achieved with injectable gonadotropins and freezing was performed using slow-cooling and vitrification methods. RESULTS: Fifty cancer patients (mean age 31 y) underwent oocyte cryopreservation; adequate ovarian stimulation was achieved in 10 +/- 0.3 days. The outcome from these cycles included a mean peak estradiol of 2,376 pg/ml and an average of 19 oocytes retrieved (15 mature oocytes were cryopreserved/cycle). All patients tolerated ovarian hyperstimulation. There were no significant differences noted between cryopreservation cycles performed in cancer patients and in women without malignancy. CONCLUSIONS: Oocyte cryopreservation appears to be a feasible fertility preservation method for reproductive-age women diagnosed with cancer. This modality is not only effective but also, providing a multidiscipline effort, can be completed in timely fashion
PMCID:2941585
PMID: 20480389
ISSN: 1573-7330
CID: 112546